Compendium of Cancer Genome Aberrations

STBT5:Volunteer Assignments and Opportunities: Difference between revisions

[checked revision][checked revision]
← Older edit
VisualWikitext
No edit summary
No edit summary
 
(10 intermediate revisions by 4 users not shown)
Line 6: Line 6:


To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.<br />
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.<br />
__TOC__
{| class="wikitable" style="margin:auto"
{| class="wikitable" style="margin:auto"
|+<big>WHO Classification of Soft Tissue and Bone Tumours (5th edition) Content</big>
|+<big>WHO Classification of Soft Tissue and Bone Tumours (5th edition) Content</big>
Line 16: Line 17:
!'''Date of Last Editor Review'''
!'''Date of Last Editor Review'''
!'''Notes'''
!'''Notes'''
!
!
!
!
!
|-
|-
|CHAPTER 2 (SOFT TISSUE TUMOURS)
|
|
----
====CHAPTER 2 (SOFT TISSUE TUMOURS)====
|
----
|
----
|
----
|
----
|
|
----
----
Line 54: Line 41:
|[[STBT5:Lipoma|Lipoma]]
|[[STBT5:Lipoma|Lipoma]]
|Disease
|Disease
|
|
|
|
|
|
|
|
|
Line 70: Line 52:
|[[STBT5:Lipomatosis|Lipomatosis]]
|[[STBT5:Lipomatosis|Lipomatosis]]
|Disease
|Disease
|
|
|
|
|
|
|
|
|
Line 86: Line 63:
|[[STBT5:Lipomatosis_of_nerve|Lipomatosis of nerve]]
|[[STBT5:Lipomatosis_of_nerve|Lipomatosis of nerve]]
|Disease
|Disease
|
|
|
|
|
|
|
|
|
Line 102: Line 74:
|[[STBT5:Lipoblastoma_and_lipoblastomatosis|Lipoblastoma and lipoblastomatosis]]
|[[STBT5:Lipoblastoma_and_lipoblastomatosis|Lipoblastoma and lipoblastomatosis]]
|Disease
|Disease
|
|
|
|
|
|
|
|
|
Line 118: Line 85:
|[[STBT5:Angiolipoma_|Angiolipoma]]
|[[STBT5:Angiolipoma_|Angiolipoma]]
|Disease
|Disease
|
|
|
|
|
|
|
|
|
Line 134: Line 96:
|[[STBT5:Myolipoma_of_soft_tissue|Myolipoma of soft tissue]]
|[[STBT5:Myolipoma_of_soft_tissue|Myolipoma of soft tissue]]
|Disease
|Disease
|
|
|
|
|
|
|
|
|
Line 150: Line 107:
|[[STBT5:Chondroid_lipoma|Chondroid lipoma]]
|[[STBT5:Chondroid_lipoma|Chondroid lipoma]]
|Disease
|Disease
|
|
|
|
|
|
|
|
|
Line 166: Line 118:
|[[STBT5:Spindle_cell_lipoma_and_pleomorphic_lipoma|Spindle cell lipoma and pleomorphic lipoma]]
|[[STBT5:Spindle_cell_lipoma_and_pleomorphic_lipoma|Spindle cell lipoma and pleomorphic lipoma]]
|Disease
|Disease
|
|
|
|
|
|
|
|
|
Line 182: Line 129:
|[[STBT5:Hibernoma|Hibernoma]]
|[[STBT5:Hibernoma|Hibernoma]]
|Disease
|Disease
|
|
|
|
|
|
|
|
|
Line 206: Line 148:
|
|
|
|
|
|-
|
|-
|
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
|
!'''Date Assigned to Author'''
|
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|-
|[[STBT5:Atypical_lipomatous_tumour_/_well-differentiated_liposarcoma|Atypical lipomatous tumour / well-differentiated liposarcoma]]
|[[STBT5:Atypical_lipomatous_tumour_/_well-differentiated_liposarcoma|Atypical lipomatous tumour / well-differentiated liposarcoma]]
|Disease
|Disease
|
|
|
|
|
|
|
|
|
Line 230: Line 171:
|[[STBT5:Dedifferentiated_liposarcoma|Dedifferentiated liposarcoma]]
|[[STBT5:Dedifferentiated_liposarcoma|Dedifferentiated liposarcoma]]
|Disease
|Disease
|
|
|
|
|
|
|
|
|
Line 246: Line 182:
|[[STBT5:Myxoid_liposarcoma|Myxoid liposarcoma]]
|[[STBT5:Myxoid_liposarcoma|Myxoid liposarcoma]]
|Disease
|Disease
|
|
|
|
|
|
|
|
|
Line 262: Line 193:
|[[STBT5:Pleomorphic_liposarcoma_|Pleomorphic liposarcoma]]
|[[STBT5:Pleomorphic_liposarcoma_|Pleomorphic liposarcoma]]
|Disease
|Disease
|
|
|
|
|
|
|
|
|
Line 278: Line 204:
|[[STBT5:Myxoid_pleomorphic_liposarcoma|Myxoid pleomorphic liposarcoma]]
|[[STBT5:Myxoid_pleomorphic_liposarcoma|Myxoid pleomorphic liposarcoma]]
|Disease
|Disease
|
|
|
|
|
|
|
|
|
Line 294: Line 215:
|[[STBT5:Nodular_fasciitis|Nodular fasciitis]]
|[[STBT5:Nodular_fasciitis|Nodular fasciitis]]
|Disease
|Disease
|
|
|
|
|
|
|
|
|
Line 315: Line 231:
|
|
|
|
|
|
|
|-
|[[STBT5:Myositis_ossificans_and_fibro-osseous_pseudotumour_of_digits|Myositis ossificans and fibro-osseous pseudotumour of digits]]
|Disease
|
|
|
|
Line 324: Line 246:
|
|
|-
|-
|[[STBT5:Myositis_ossificans_and_fibro-osseous_pseudotumour_of_digits|Myositis ossificans and fibro-osseous pseudotumour of digits]]
|[[STBT5:Ischaemic_fasciitis|Ischaemic fasciitis]]
|Disease
|Disease
|
|
Line 333: Line 255:
|
|
|
|
|
|-
|[[STBT5:Elastofibroma|Elastofibroma]]
|Disease
|
|
|
|
Line 339: Line 265:
|
|
|
|
|
|
|-
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|-
|[[STBT5:Ischaemic_fasciitis|Ischaemic fasciitis]]
|[[STBT5:Fibrous_hamartoma_of_infancy|Fibrous hamartoma of infancy]]
|Disease
|Disease
|
|
Line 350: Line 287:
|
|
|
|
|-
|[[STBT5:Fibromatosis_colli|Fibromatosis colli]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Elastofibroma|Elastofibroma]]
|Disease
|
|
|
|
Line 363: Line 298:
|
|
|
|
|-
|[[STBT5:Juvenile_hyaline_fibromatosis|Juvenile hyaline fibromatosis]]
|Disease
|
|
|
|
Line 372: Line 310:
|
|
|-
|-
|[[STBT5:Fibrous_hamartoma_of_infancy|Fibrous hamartoma of infancy]]
|[[STBT5:Inclusion_body_fibromatosis|Inclusion body fibromatosis]]
|Disease
|Disease
|
|
Line 382: Line 320:
|
|
|
|
|-
|[[STBT5:Fibroma_of_tendon_sheath|Fibroma of tendon sheath]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Fibromatosis_colli|Fibromatosis colli]]
|Disease
|
|
|
|
Line 395: Line 331:
|
|
|
|
|-
|[[STBT5:Desmoplastic_fibroblastoma|Desmoplastic fibroblastoma]]
|Disease
|
|
|
|
Line 404: Line 343:
|
|
|-
|-
|[[STBT5:Juvenile_hyaline_fibromatosis|Juvenile hyaline fibromatosis]]
|[[STBT5:Myofibroblastoma|Myofibroblastoma]]
|Disease
|Disease
|
|
|
|
|
|
|
|
|
Line 420: Line 354:
|
|
|-
|-
|[[STBT5:Inclusion_body_fibromatosis|Inclusion body fibromatosis]]
|[[STBT5:Calcifying_aponeurotic_fibroma|Calcifying aponeurotic fibroma]]
|Disease
|Disease
|
|
|
|
|
|
|
|
|
Line 436: Line 365:
|
|
|-
|-
|[[STBT5:Fibroma_of_tendon_sheath|Fibroma of tendon sheath]]
|[[STBT5:EWSR1-SMAD3-positive_fibroblastic_tumour_(emerging)|EWSR1-SMAD3-positive fibroblastic tumour (emerging)]]
|Disease
|Disease
|
|
|
|
|
|
|
|
|
Line 452: Line 376:
|
|
|-
|-
|[[STBT5:Desmoplastic_fibroblastoma|Desmoplastic fibroblastoma]]
|[[STBT5:Angiomyofibroblastoma|Angiomyofibroblastoma]]
|Disease
|Disease
|
|
Line 459: Line 383:
|
|
|
|
|
|
|
|-
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Cellular_angiofibroma|Cellular angiofibroma]]
|Disease
|
|
|
|
Line 468: Line 407:
|
|
|-
|-
|[[STBT5:Myofibroblastoma|Myofibroblastoma]]
|[[STBT5:Angiofibroma_of_soft_tissue|Angiofibroma of soft tissue]]
|Disease
|Disease
|
|
Line 478: Line 417:
|
|
|
|
|-
|[[STBT5:Nuchal-type_fibroma|Nuchal-type fibroma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Calcifying_aponeurotic_fibroma|Calcifying aponeurotic fibroma]]
|Disease
|
|
|
|
Line 491: Line 428:
|
|
|
|
|-
|[[STBT5:Acral_fibromyxoma|Acral fibromyxoma]]
|Disease
|
|
|
|
Line 500: Line 440:
|
|
|-
|-
|[[STBT5:EWSR1-SMAD3-positive_fibroblastic_tumour_(emerging)|EWSR1-SMAD3-positive fibroblastic tumour (emerging)]]
|[[STBT5:Gardner_fibroma|Gardner fibroma]]
|Disease
|Disease
|
|
Line 507: Line 447:
|
|
|
|
|
|
|
|-
|[[STBT5:Palmar_fibromatosis_and_plantar_fibromatosis|Palmar fibromatosis and plantar fibromatosis]]
|Disease
|
|
|
|
Line 516: Line 462:
|
|
|-
|-
|[[STBT5:Angiomyofibroblastoma|Angiomyofibroblastoma]]
|[[STBT5:Desmoid_fibromatosis|Desmoid fibromatosis]]
|Disease
|Disease
|
|
|
|
|
|
|
|
|
Line 532: Line 473:
|
|
|-
|-
|[[STBT5:Cellular_angiofibroma|Cellular angiofibroma]]
|[[STBT5:Lipofibromatosis|Lipofibromatosis]]
|Disease
|Disease
|
|
|
|
|
|
|
|
|
Line 548: Line 484:
|
|
|-
|-
|[[STBT5:Angiofibroma_of_soft_tissue|Angiofibroma of soft tissue]]
|[[STBT5:Giant_cell_fibroblastoma|Giant cell fibroblastoma]]
|Disease
|Disease
|
|
|
|
|
|
|
|
|
Line 564: Line 495:
|
|
|-
|-
|[[STBT5:Nuchal-type_fibroma|Nuchal-type fibroma]]
|[[STBT5:Dermatofibrosarcoma_protuberans|Dermatofibrosarcoma protuberans]]
|Disease
|Disease
|
|
Line 574: Line 505:
|
|
|
|
|
|
|
|
|
|-
|-
|[[STBT5:Acral_fibromyxoma|Acral fibromyxoma]]
|-
|Disease
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
|Disease
|Shashi Shetty and Reba Daniel (resident)
|2/21/2024
|
|PENDING
|
|
|Katherine Geiersbach
|
|
|Template added 2/21/2024
|-
|[[STBT5:Inflammatory_myofibroblastic_tumour|Inflammatory myofibroblastic tumour]]
|Disease
|
|
|
|
Line 592: Line 536:
|
|
|
|
|-
|[[STBT5:Low-grade_myofibroblastic_sarcoma|Low-grade myofibroblastic sarcoma]]
|Disease
|
|
|
|
|
|
|-
|[[STBT5:Gardner_fibroma|Gardner fibroma]]
|Disease
|
|
|
|
Line 603: Line 547:
|
|
|
|
|-
|[[STBT5:Superficial_CD34-positive_fibroblastic_tumour|Superficial CD34-positive fibroblastic tumour]]
|Disease
|
|
|
|
Line 612: Line 559:
|
|
|-
|-
|[[STBT5:Palmar_fibromatosis_and_plantar_fibromatosis|Palmar fibromatosis and plantar fibromatosis]]
|[[STBT5:Myxoinflammatory_fibroblastic_sarcoma|Myxoinflammatory fibroblastic sarcoma]]
|Disease
|Disease
|
|
Line 622: Line 569:
|
|
|
|
|
|-
|[[STBT5:Infantile_fibrosarcoma|Infantile fibrosarcoma]]
|Disease
|Katie Schieffer
|4/21/2025
|10/1/2025
|PENDING
|
|
|
|
Line 628: Line 581:
|
|
|-
|-
|[[STBT5:Desmoid_fibromatosis|Desmoid fibromatosis]]
|[[STBT5:Adult_fibrosarcoma|Adult fibrosarcoma]]
|Disease
|Disease
|
|
Line 638: Line 591:
|
|
|
|
|-
|[[STBT5:Myxofibrosarcoma|Myxofibrosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Lipofibromatosis|Lipofibromatosis]]
|Disease
|
|
|
|
Line 651: Line 602:
|
|
|
|
|-
|[[STBT5:Low-grade_fibromyxoid_sarcoma|Low-grade fibromyxoid sarcoma]]
|Disease
|
|
|
|
Line 660: Line 614:
|
|
|-
|-
|[[STBT5:Giant_cell_fibroblastoma|Giant cell fibroblastoma]]
|[[STBT5:Sclerosing_epithelioid_fibrosarcoma|Sclerosing epithelioid fibrosarcoma]]
|Disease
|Disease
|
|
Line 670: Line 624:
|
|
|
|
|-
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Tenosynovial_giant_cell_tumour|Tenosynovial giant cell tumour]]
|Disease
|
|
|
|
Line 675: Line 641:
|
|
|
|
|-
|[[STBT5:Dermatofibrosarcoma_protuberans|Dermatofibrosarcoma protuberans]]
|Disease
|
|
|
|
|
|
|-
|[[STBT5:Deep_fibrous_histiocytoma|Deep fibrous histiocytoma]]
|Disease
|
|
|
|
Line 689: Line 655:
|
|
|
|
|
|-
|
|[[STBT5:Plexiform_fibrohistiocytic_tumour|Plexiform fibrohistiocytic tumour]]
|-
|[[STBT5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
|Disease
|Disease
|Shashi Shetty and Reba Daniel (resident)
|2/21/2024
|
|
|PENDING
|
|
|Katherine Geiersbach
|
|
|Template added 2/21/2024
|
|
|
|
Line 708: Line 667:
|
|
|-
|-
|[[STBT5:Inflammatory_myofibroblastic_tumour|Inflammatory myofibroblastic tumour]]
|[[STBT5:Giant_cell_tumour_of_soft_tissue|Giant cell tumour of soft tissue]]
|Disease
|Disease
|
|
Line 718: Line 677:
|
|
|
|
|-
|[[STBT5:Synovial_haemangioma|Synovial haemangioma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Low-grade_myofibroblastic_sarcoma|Low-grade myofibroblastic sarcoma]]
|Disease
|
|
|
|
Line 731: Line 688:
|
|
|
|
|-
|[[STBT5:Intramuscular_angioma|Intramuscular angioma]]
|Disease
|
|
|
|
Line 740: Line 700:
|
|
|-
|-
|[[STBT5:Superficial_CD34-positive_fibroblastic_tumour|Superficial CD34-positive fibroblastic tumour]]
|[[STBT5:Arteriovenous_malformation/haemangioma|Arteriovenous malformation/haemangioma]]
|Disease
|Disease
|
|
Line 750: Line 710:
|
|
|
|
|-
|[[STBT5:Venous_haemangioma|Venous haemangioma]]
|Disease
|
|
|
|
Line 755: Line 718:
|
|
|
|
|-
|[[STBT5:Myxoinflammatory_fibroblastic_sarcoma|Myxoinflammatory fibroblastic sarcoma]]
|Disease
|
|
|
|
|
|
|-
|[[STBT5:Anastomosing_haemangioma|Anastomosing haemangioma]]
|Disease
|
|
|
|
Line 768: Line 731:
|
|
|
|
|
|-
|[[STBT5:Epithelioid_haemangioma|Epithelioid haemangioma]]
|Disease
|
|
|
|
|
|
|-
|[[STBT5:Infantile_fibrosarcoma|Infantile fibrosarcoma]]
|Disease
|
|
|
|
Line 779: Line 743:
|
|
|
|
|-
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Lymphangioma_and_lymphangiomatosis|Lymphangioma and lymphangiomatosis]]
|Disease
|
|
|
|
Line 788: Line 764:
|
|
|-
|-
|[[STBT5:Adult_fibrosarcoma|Adult fibrosarcoma]]
|[[STBT5:Tufted_angioma_and_kaposiform_haemangioendothelioma|Tufted angioma and kaposiform haemangioendothelioma]]
|Disease
|Disease
|
|
Line 798: Line 774:
|
|
|
|
|-
|[[STBT5:Retiform_haemangioendothelioma|Retiform haemangioendothelioma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Myxofibrosarcoma|Myxofibrosarcoma]]
|Disease
|
|
|
|
Line 811: Line 785:
|
|
|
|
|-
|[[STBT5:Papillary_intralymphatic_angioendothelioma|Papillary intralymphatic angioendothelioma]]
|Disease
|
|
|
|
Line 820: Line 797:
|
|
|-
|-
|[[STBT5:Low-grade_fibromyxoid_sarcoma|Low-grade fibromyxoid sarcoma]]
|[[STBT5:Composite_haemangioendothelioma_|Composite haemangioendothelioma]]
|Disease
|Disease
|
|
|
|
|
|
|
|
|
Line 836: Line 808:
|
|
|-
|-
|[[STBT5:Sclerosing_epithelioid_fibrosarcoma|Sclerosing epithelioid fibrosarcoma]]
|[[STBT5:Kaposi_sarcoma|Kaposi sarcoma]]
|Disease
|Disease
|
|
|
|
|
|
|
|
|
Line 852: Line 819:
|
|
|-
|-
|[[STBT5:Tenosynovial_giant_cell_tumour|Tenosynovial giant cell tumour]]
|[[STBT5:Pseudomyogenic_haemangioendothelioma|Pseudomyogenic haemangioendothelioma]]
|Disease
|Disease
|
|
|
|
|
|
|
|
|
Line 868: Line 830:
|
|
|-
|-
|[[STBT5:Deep_fibrous_histiocytoma|Deep fibrous histiocytoma]]
|[[STBT5:Epithelioid_haemangioendothelioma|Epithelioid haemangioendothelioma]]
|Disease
|Disease
|
|
|
|
|
|
|
|
|
Line 884: Line 841:
|
|
|-
|-
|[[STBT5:Plexiform_fibrohistiocytic_tumour|Plexiform fibrohistiocytic tumour]]
|[[STBT5:Angiosarcoma|Angiosarcoma]]
|Disease
|Disease
|
|
Line 894: Line 851:
|
|
|
|
|-
|[[STBT5:Glomus_tumour|Glomus tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Giant_cell_tumour_of_soft_tissue|Giant cell tumour of soft tissue]]
|Disease
|
|
|
|
Line 907: Line 862:
|
|
|
|
|-
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Myopericytoma,_including_myofibroma|Myopericytoma, including myofibroma]]
|Disease
|
|
|
|
Line 916: Line 883:
|
|
|-
|-
|[[STBT5:Synovial_haemangioma|Synovial haemangioma]]
|[[STBT5:Angioleiomyoma|Angioleiomyoma]]
|Disease
|Disease
|
|
Line 926: Line 893:
|
|
|
|
|-
|[[STBT5:Leiomyoma|Leiomyoma]]
|Disease
|
|
|
|
Line 931: Line 901:
|
|
|
|
|-
|[[STBT5:Intramuscular_angioma|Intramuscular angioma]]
|Disease
|
|
|
|
|
|
|-
|[[STBT5:EBV-associated_smooth_muscle_tumour|EBV-associated smooth muscle tumour]]
|Disease
|
|
|
|
Line 945: Line 915:
|
|
|
|
|-
|[[STBT5:Inflammatory_leiomyosarcoma|Inflammatory leiomyosarcoma]]
|Disease
|
|
|
|
|-
|[[STBT5:Arteriovenous_malformation/haemangioma|Arteriovenous malformation/haemangioma]]
|Disease
|
|
|
|
Line 955: Line 925:
|
|
|
|
|
|-
|[[STBT5:Leiomyosarcoma|Leiomyosarcoma]]
|Disease
|
|
|
|
Line 964: Line 938:
|
|
|-
|-
|[[STBT5:Venous_haemangioma|Venous haemangioma]]
|[[STBT5:Rhabdomyoma|Rhabdomyoma]]
|Disease
|Disease
|
|
Line 974: Line 948:
|
|
|
|
|-
|[[STBT5:Embryonal_rhabdomyosarcoma|Embryonal rhabdomyosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Anastomosing_haemangioma|Anastomosing haemangioma]]
|Disease
|
|
|
|
Line 987: Line 959:
|
|
|
|
|-
|[[STBT5:Alveolar_rhabdomyosarcoma|Alveolar rhabdomyosarcoma]]
|Disease
|
|
|
|
Line 996: Line 971:
|
|
|-
|-
|[[STBT5:Epithelioid_haemangioma|Epithelioid haemangioma]]
|[[STBT5:Pleomorphic_rhabdomyosarcoma|Pleomorphic rhabdomyosarcoma]]
|Disease
|Disease
|
|
Line 1,006: Line 981:
|
|
|
|
|-
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Spindle_cell_/_sclerosing_rhabdomyosarcoma|Spindle cell / sclerosing rhabdomyosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Lymphangioma_and_lymphangiomatosis|Lymphangioma and lymphangiomatosis]]
|Disease
|
|
|
|
Line 1,019: Line 1,001:
|
|
|
|
|-
|[[STBT5:Ectomesenchymoma|Ectomesenchymoma]]
|Disease
|
|
|
|
Line 1,028: Line 1,013:
|
|
|-
|-
|[[STBT5:Tufted_angioma_and_kaposiform_haemangioendothelioma|Tufted angioma and kaposiform haemangioendothelioma]]
|[[STBT5:Gastrointestinal_stromal_tumour|Gastrointestinal stromal tumour]]
|Disease
|Disease
|
|
Line 1,038: Line 1,023:
|
|
|
|
|-
|[[STBT5:Soft_tissue_chondroma|Soft tissue chondroma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Retiform_haemangioendothelioma|Retiform haemangioendothelioma]]
|Disease
|
|
|
|
Line 1,051: Line 1,034:
|
|
|
|
|-
|[[STBT5:Extraskeletal_osteosarcoma|Extraskeletal osteosarcoma]]
|Disease
|
|
|
|
Line 1,060: Line 1,046:
|
|
|-
|-
|[[STBT5:Papillary_intralymphatic_angioendothelioma|Papillary intralymphatic angioendothelioma]]
|[[STBT5:Schwannoma|Schwannoma]]
|Disease
|Disease
|
|
Line 1,070: Line 1,056:
|
|
|
|
|-
|[[STBT5:Neurofibroma|Neurofibroma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Composite_haemangioendothelioma_|Composite haemangioendothelioma]]
|Disease
|
|
|
|
Line 1,083: Line 1,067:
|
|
|
|
|-
|[[STBT5:Perineurioma|Perineurioma]]
|Disease
|
|
|
|
Line 1,092: Line 1,079:
|
|
|-
|-
|[[STBT5:Kaposi_sarcoma|Kaposi sarcoma]]
|[[STBT5:Granular_cell_tumour|Granular cell tumour]]
|Disease
|Disease
|
|
Line 1,099: Line 1,086:
|
|
|
|
|
|
|
|-
|[[STBT5:Dermal_nerve_sheath_myxoma|Dermal nerve sheath myxoma]]
|Disease
|
|
|
|
Line 1,108: Line 1,101:
|
|
|-
|-
|[[STBT5:Pseudomyogenic_haemangioendothelioma|Pseudomyogenic haemangioendothelioma]]
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Solitary_circumscribed_neuroma|Solitary circumscribed neuroma]]
|Disease
|Disease
|
|
Line 1,115: Line 1,117:
|
|
|
|
|
|
|
|-
|[[STBT5:Ectopic_meningioma_and_meningothelial_hamartoma|Ectopic meningioma and meningothelial hamartoma]]
|Disease
|
|
|
|
Line 1,124: Line 1,132:
|
|
|-
|-
|[[STBT5:Epithelioid_haemangioendothelioma|Epithelioid haemangioendothelioma]]
|[[STBT5:Benign_triton_tumour_/_neuromuscular_choristoma|Benign triton tumour / neuromuscular choristoma]]
|Disease
|Disease
|
|
Line 1,134: Line 1,142:
|
|
|
|
|-
|[[STBT5:Hybrid_nerve_sheath_tumour|Hybrid nerve sheath tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Angiosarcoma|Angiosarcoma]]
|Disease
|
|
|
|
Line 1,147: Line 1,153:
|
|
|
|
|-
|[[STBT5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
|Disease
|
|
|
|
Line 1,156: Line 1,165:
|
|
|-
|-
|[[STBT5:Glomus_tumour|Glomus tumour]]
|[[STBT5:Malignant_melanotic_nerve_sheath_tumour|Malignant melanotic nerve sheath tumour]]
|Disease
|Disease
|
|
Line 1,163: Line 1,172:
|
|
|
|
|
|
|
|-
|[[STBT5:Intramuscular_myxoma|Intramuscular myxoma]]
|Disease
|
|
|
|
Line 1,172: Line 1,187:
|
|
|-
|-
|[[STBT5:Myopericytoma,_including_myofibroma|Myopericytoma, including myofibroma]]
|[[STBT5:Juxta-articular_myxoma|Juxta-articular myxoma]]
|Disease
|Disease
|
|
Line 1,182: Line 1,197:
|
|
|
|
|-
|[[STBT5:Deep_(aggressive)_angiomyxoma|Deep (aggressive) angiomyxoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Angioleiomyoma|Angioleiomyoma]]
|Disease
|
|
|
|
Line 1,195: Line 1,208:
|
|
|
|
|-
|[[STBT5:Atypical_fibroxanthoma|Atypical fibroxanthoma]]
|Disease
|
|
|
|
Line 1,204: Line 1,220:
|
|
|-
|-
|[[STBT5:Leiomyoma|Leiomyoma]]
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Angiomatoid_fibrous_histiocytoma|Angiomatoid fibrous histiocytoma]]
|Disease
|Disease
|
|
Line 1,211: Line 1,236:
|
|
|
|
|
|
|
|-
|[[STBT5:Ossifying_fibromyxoid_tumour|Ossifying fibromyxoid tumour]]
|Disease
|
|
|
|
Line 1,220: Line 1,251:
|
|
|-
|-
|[[STBT5:EBV-associated_smooth_muscle_tumour|EBV-associated smooth muscle tumour]]
|[[STBT5:Myoepithelioma,_myoepithelial_carcinoma,_and_mixed_tumour|Myoepithelioma, myoepithelial carcinoma, and mixed tumour]]
|Disease
|Disease
|
|
Line 1,230: Line 1,261:
|
|
|
|
|-
|[[STBT5:Pleomorphic_hyalinizing_angiectatic_tumour_of_soft_parts|Pleomorphic hyalinizing angiectatic tumour of soft parts]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Inflammatory_leiomyosarcoma|Inflammatory leiomyosarcoma]]
|Disease
|
|
|
|
Line 1,243: Line 1,272:
|
|
|
|
|-
|[[STBT5:Haemosiderotic_fibrolipomatous_tumour|Haemosiderotic fibrolipomatous tumour]]
|Disease
|
|
|
|
Line 1,252: Line 1,284:
|
|
|-
|-
|[[STBT5:Leiomyosarcoma|Leiomyosarcoma]]
|[[STBT5:Phosphaturic_mesenchymal_tumour|Phosphaturic mesenchymal tumour]]
|Disease
|Disease
|
|
Line 1,262: Line 1,294:
|
|
|
|
|-
|[[STBT5:NTRK-rearranged_spindle_cell_neoplasm_(emerging)|NTRK-rearranged spindle cell neoplasm (emerging)]]
|Disease
|James Solomon, MD, PhD
|2/20/2022
|12/9/2025
|PENDING
|
|
|
|Katie Schieffer
|
|
|
|
|
|-
|-
|[[STBT5:Rhabdomyoma|Rhabdomyoma]]
|[[STBT5:Synovial_sarcoma|Synovial sarcoma]]
|Disease
|Disease
|
|
|
|
|
|
|
|
|
Line 1,284: Line 1,317:
|
|
|-
|-
|[[STBT5:Embryonal_rhabdomyosarcoma|Embryonal rhabdomyosarcoma]]
|[[STBT5:Epithelioid_sarcoma|Epithelioid sarcoma]]
|Disease
|Disease
|
|
Line 1,291: Line 1,324:
|
|
|
|
|
|
|
|-
|[[STBT5:Alveolar_soft_part_sarcoma|Alveolar soft part sarcoma]]
|Disease
|
|
|
|
Line 1,300: Line 1,339:
|
|
|-
|-
|[[STBT5:Alveolar_rhabdomyosarcoma|Alveolar rhabdomyosarcoma]]
|[[STBT5:Clear_cell_sarcoma_of_soft_tissue|Clear cell sarcoma of soft tissue]]
|Disease
|Disease
|
|
Line 1,310: Line 1,349:
|
|
|
|
|-
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Extraskeletal_myxoid_chondrosarcoma_|Extraskeletal myxoid chondrosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Pleomorphic_rhabdomyosarcoma|Pleomorphic rhabdomyosarcoma]]
|Disease
|
|
|
|
Line 1,323: Line 1,369:
|
|
|
|
|-
|[[STBT5:Desmoplastic_small_round_cell_tumour|Desmoplastic small round cell tumour]]
|Disease
|
|
|
|
Line 1,332: Line 1,381:
|
|
|-
|-
|[[STBT5:Spindle_cell_/_sclerosing_rhabdomyosarcoma|Spindle cell / sclerosing rhabdomyosarcoma]]
|[[STBT5:Extrarenal_rhabdoid_tumour|Extrarenal rhabdoid tumour]]
|Disease
|Disease
|
|
Line 1,339: Line 1,388:
|
|
|
|
|
|
|
|-
|[[STBT5:PEComa|PEComa]]
|Disease
|
|
|
|
Line 1,348: Line 1,403:
|
|
|-
|-
|[[STBT5:Ectomesenchymoma|Ectomesenchymoma]]
|[[STBT5:Intimal_sarcoma|Intimal sarcoma]]
|Disease
|Disease
|
|
Line 1,358: Line 1,413:
|
|
|
|
|-
|[[STBT5:Undifferentiated_sarcoma|Undifferentiated sarcoma]]
|Disease
|
|
|
|
Line 1,363: Line 1,421:
|
|
|
|
|-
|[[STBT5:Gastrointestinal_stromal_tumour|Gastrointestinal stromal tumour]]
|Disease
|
|
|
|
|
|
|-
|
|
====CHAPTER 3 (UNDIFFERENTIATED SMALL ROUND CELL SARCOMAS OF BONE AND SOFT TISSUE)====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|-
|-
|[[STBT5:Soft_tissue_chondroma|Soft tissue chondroma]]
|[[STBT5:Ewing_sarcoma|Ewing sarcoma]]
|Disease
|Disease
|Sadeem Qdaisat
|10/1/23
|12/9/2025
|PENDING
|
|
|Working with Eric McGinnis
|
|
|2021 template added
|-
|[[STBT5:Round_cell_sarcoma_with_EWSR1-non-ETS_fusions|Round cell sarcoma with EWSR1-non-ETS fusions]]
|Disease
|
|
|
|
Line 1,392: Line 1,467:
|
|
|
|
|-
|[[STBT5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]]
|Disease
|Ganesh Pandurang, MD
|2/28/24
|
|
|PENDING
|
|Katherine Geiersbach
|
|
|
|
|-
|-
|[[STBT5:Extraskeletal_osteosarcoma|Extraskeletal osteosarcoma]]
|[[STBT5:Sarcoma_with_BCOR_genetic_alterations|Sarcoma with BCOR genetic alterations]]
|Disease
|Disease
|
|
Line 1,406: Line 1,489:
|
|
|
|
|-
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|
|
====CHAPTER 4 (BONE TUMOURS)====
|
|
----
|
|
----
|
|
----
|
|
|-
----
|[[STBT5:Schwannoma|Schwannoma]]
|Disease
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|-
|[[STBT5:Subungual_exostosis|Subungual exostosis]]
|Disease
|
|
|
|
Line 1,428: Line 1,531:
|
|
|-
|-
|[[STBT5:Neurofibroma|Neurofibroma]]
|[[STBT5:Bizarre_parosteal_osteochondromatous_proliferation|Bizarre parosteal osteochondromatous proliferation]]
|Disease
|Disease
|
|
Line 1,435: Line 1,538:
|
|
|
|
|
|
|
|-
|[[STBT5:Periosteal_chondroma|Periosteal chondroma]]
|Disease
|
|
|
|
Line 1,444: Line 1,553:
|
|
|-
|-
|[[STBT5:Perineurioma|Perineurioma]]
|[[STBT5:Enchondroma|Enchondroma]]
|Disease
|Disease
|
|
Line 1,454: Line 1,563:
|
|
|
|
|-
|[[STBT5:Osteochondroma|Osteochondroma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Granular_cell_tumour|Granular cell tumour]]
|Disease
|
|
|
|
Line 1,467: Line 1,574:
|
|
|
|
|-
|[[STBT5:Chondroblastoma|Chondroblastoma]]
|Disease
|
|
|
|
Line 1,476: Line 1,586:
|
|
|-
|-
|[[STBT5:Dermal_nerve_sheath_myxoma|Dermal nerve sheath myxoma]]
|[[STBT5:Chondromyxoid_fibroma|Chondromyxoid fibroma]]
|Disease
|Disease
|
|
Line 1,486: Line 1,596:
|
|
|
|
|-
|[[STBT5:Osteochondromyxoma|Osteochondromyxoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Solitary_circumscribed_neuroma|Solitary circumscribed neuroma]]
|Disease
|
|
|
|
Line 1,499: Line 1,607:
|
|
|
|
|-
|[[STBT5:Synovial_chondromatosis|Synovial chondromatosis]]
|Disease
|
|
|
|
Line 1,508: Line 1,619:
|
|
|-
|-
|[[STBT5:Ectopic_meningioma_and_meningothelial_hamartoma|Ectopic meningioma and meningothelial hamartoma]]
|[[STBT5:Central_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Central atypical cartilaginous tumour / chondrosarcoma, grade 1]]
|Disease
|Disease
|
|
Line 1,518: Line 1,629:
|
|
|
|
|-
|[[STBT5:Secondary_peripheral_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Secondary peripheral atypical cartilaginous tumour / chondrosarcoma, grade 1]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Benign_triton_tumour_/_neuromuscular_choristoma|Benign triton tumour / neuromuscular choristoma]]
|Disease
|
|
|
|
Line 1,531: Line 1,640:
|
|
|
|
|-
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Central_chondrosarcoma,_grades_2_and_3|Central chondrosarcoma, grades 2 and 3]]
|Disease
|
|
|
|
Line 1,540: Line 1,661:
|
|
|-
|-
|[[STBT5:Hybrid_nerve_sheath_tumour|Hybrid nerve sheath tumour]]
|[[STBT5:Secondary_peripheral_chondrosarcoma,_grades_2_and_3|Secondary peripheral chondrosarcoma, grades 2 and 3]]
|Disease
|Disease
|
|
Line 1,550: Line 1,671:
|
|
|
|
|-
|[[STBT5:Periosteal_chondrosarcoma|Periosteal chondrosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
|Disease
|
|
|
|
Line 1,563: Line 1,682:
|
|
|
|
|-
|[[STBT5:Clear_cell_chondrosarcoma|Clear cell chondrosarcoma]]
|Disease
|
|
|
|
Line 1,572: Line 1,694:
|
|
|-
|-
|[[STBT5:Malignant_melanotic_nerve_sheath_tumour|Malignant melanotic nerve sheath tumour]]
|[[STBT5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]]
|Disease
|Disease
|
|
Line 1,582: Line 1,704:
|
|
|
|
|-
|[[STBT5:Dedifferentiated_chondrosarcoma_|Dedifferentiated chondrosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Intramuscular_myxoma|Intramuscular myxoma]]
|Disease
|
|
|
|
Line 1,595: Line 1,715:
|
|
|
|
|-
|[[STBT5:Osteoma|Osteoma]]
|Disease
|
|
|
|
Line 1,604: Line 1,727:
|
|
|-
|-
|[[STBT5:Juxta-articular_myxoma|Juxta-articular myxoma]]
|[[STBT5:Osteoid_osteoma_|Osteoid osteoma]]
|Disease
|Disease
|
|
Line 1,614: Line 1,737:
|
|
|
|
|-
|[[STBT5:Osteoblastoma_|Osteoblastoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Deep_(aggressive)_angiomyxoma|Deep (aggressive) angiomyxoma]]
|Disease
|
|
|
|
Line 1,627: Line 1,748:
|
|
|
|
|-
|[[STBT5:Low-grade_central_osteosarcoma|Low-grade central osteosarcoma]]
|Disease
|
|
|
|
Line 1,636: Line 1,760:
|
|
|-
|-
|[[STBT5:Atypical_fibroxanthoma|Atypical fibroxanthoma]]
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Osteosarcoma|Osteosarcoma]]
|Disease
|Disease
|
|
Line 1,646: Line 1,779:
|
|
|
|
|-
|[[STBT5:Parosteal_osteosarcoma_|Parosteal osteosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Angiomatoid_fibrous_histiocytoma|Angiomatoid fibrous histiocytoma]]
|Disease
|
|
|
|
Line 1,659: Line 1,790:
|
|
|
|
|-
|[[STBT5:Periosteal_osteosarcoma_|Periosteal osteosarcoma]]
|Disease
|
|
|
|
Line 1,668: Line 1,802:
|
|
|-
|-
|[[STBT5:Ossifying_fibromyxoid_tumour|Ossifying fibromyxoid tumour]]
|[[STBT5:High-grade_surface_osteosarcoma|High-grade surface osteosarcoma]]
|Disease
|Disease
|
|
Line 1,678: Line 1,812:
|
|
|
|
|-
|[[STBT5:Secondary_osteosarcoma|Secondary osteosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Myoepithelioma,_myoepithelial_carcinoma,_and_mixed_tumour|Myoepithelioma, myoepithelial carcinoma, and mixed tumour]]
|Disease
|
|
|
|
Line 1,691: Line 1,823:
|
|
|
|
|-
|[[STBT5:Desmoplastic_fibroma_of_bone|Desmoplastic fibroma of bone]]
|Disease
|
|
|
|
Line 1,700: Line 1,835:
|
|
|-
|-
|[[STBT5:Pleomorphic_hyalinizing_angiectatic_tumour_of_soft_parts|Pleomorphic hyalinizing angiectatic tumour of soft parts]]
|[[STBT5:Fibrosarcoma_of_bone|Fibrosarcoma of bone]]
|Disease
|Disease
|
|
Line 1,710: Line 1,845:
|
|
|
|
|-
|[[STBT5:Haemangioma_of_bone|Haemangioma of bone]]
|Disease
|
|
|
|
Line 1,715: Line 1,853:
|
|
|
|
|-
|[[STBT5:Haemosiderotic_fibrolipomatous_tumour|Haemosiderotic fibrolipomatous tumour]]
|Disease
|
|
|
|
|
|
|-
|[[STBT5:Epithelioid_haemangioma_of_bone|Epithelioid haemangioma of bone]]
|Disease
|
|
|
|
Line 1,728: Line 1,866:
|
|
|
|
|
|-
|[[STBT5:Epithelioid_haemangioendothelioma_of_bone|Epithelioid haemangioendothelioma of bone]]
|Disease
|
|
|
|
|
|
|-
|[[STBT5:Phosphaturic_mesenchymal_tumour|Phosphaturic mesenchymal tumour]]
|Disease
|
|
|
|
Line 1,739: Line 1,878:
|
|
|
|
|-
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Angiosarcoma_of_bone|Angiosarcoma of bone]]
|Disease
|
|
|
|
Line 1,748: Line 1,899:
|
|
|-
|-
|[[STBT5:NTRK-rearranged_spindle_cell_neoplasm_(emerging)|NTRK-rearranged spindle cell neoplasm (emerging)]]
|[[STBT5:Aneurysmal_bone_cyst|Aneurysmal bone cyst]]
|Disease
|Disease
|James Solomon, MD, PhD
|2/20/2022
|
|PENDING
|
|
|Alanna Church
|
|
|
|
Line 1,764: Line 1,910:
|
|
|-
|-
|[[STBT5:Synovial_sarcoma|Synovial sarcoma]]
|[[STBT5:Giant_cell_tumour_of_bone_|Giant cell tumour of bone]]
|Disease
|Disease
|
|
|
|
|
|
|
|
|
Line 1,780: Line 1,921:
|
|
|-
|-
|[[STBT5:Epithelioid_sarcoma|Epithelioid sarcoma]]
|[[STBT5:Non-ossifying_fibroma|Non-ossifying fibroma]]
|Disease
|Disease
|
|
Line 1,790: Line 1,931:
|
|
|
|
|-
|[[STBT5:Benign_notochordal_cell_tumour_|Benign notochordal cell tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Alveolar_soft_part_sarcoma|Alveolar soft part sarcoma]]
|Disease
|
|
|
|
Line 1,803: Line 1,942:
|
|
|
|
|-
|[[STBT5:Conventional_chordoma|Conventional chordoma]]
|Disease
|
|
|
|
Line 1,812: Line 1,954:
|
|
|-
|-
|[[STBT5:Clear_cell_sarcoma_of_soft_tissue|Clear cell sarcoma of soft tissue]]
|[[STBT5:Dedifferentiated_chordoma|Dedifferentiated chordoma]]
|Disease
|Disease
|
|
|
|
|
|
|
|
|
Line 1,828: Line 1,965:
|
|
|-
|-
|[[STBT5:Extraskeletal_myxoid_chondrosarcoma_|Extraskeletal myxoid chondrosarcoma]]
|[[STBT5:Poorly_differentiated_chordoma|Poorly differentiated chordoma]]
|Disease
|Disease
|
|
|
|
|
|
|
|
|
Line 1,844: Line 1,976:
|
|
|-
|-
|[[STBT5:Desmoplastic_small_round_cell_tumour|Desmoplastic small round cell tumour]]
|[[STBT5:Chondromesenchymal_hamartoma_of_chest_wall|Chondromesenchymal hamartoma of chest wall]]
|Disease
|Disease
|
|
|
|
|
|
|
|
|
Line 1,860: Line 1,987:
|
|
|-
|-
|[[STBT5:Extrarenal_rhabdoid_tumour|Extrarenal rhabdoid tumour]]
|[[STBT5:Osteofibrous_dysplasia_|Osteofibrous dysplasia]]
|Disease
|Disease
|
|
Line 1,867: Line 1,994:
|
|
|
|
|
|
|
|-
|-
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[STBT5:Adamantinoma_of_long_bones|Adamantinoma of long bones]]
|Disease
|
|
|
|
Line 1,876: Line 2,018:
|
|
|-
|-
|[[STBT5:PEComa|PEComa]]
|[[STBT5:Simple_bone_cyst|Simple bone cyst]]
|Disease
|Disease
|
|
Line 1,886: Line 2,028:
|
|
|
|
|-
|[[STBT5:Fibrocartilaginous_mesenchymoma|Fibrocartilaginous mesenchymoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[STBT5:Intimal_sarcoma|Intimal sarcoma]]
|Disease
|
|
|
|
Line 1,899: Line 2,039:
|
|
|
|
|-
|[[STBT5:Fibrous_dysplasia|Fibrous dysplasia]]
|Disease
|
|
|
|
Line 1,908: Line 2,051:
|
|
|-
|-
|[[STBT5:Undifferentiated_sarcoma|Undifferentiated sarcoma]]
|[[STBT5:Lipoma_and_hibernoma_of_bone|Lipoma and hibernoma of bone]]
|Disease
|Disease
|
|
Line 1,918: Line 2,061:
|
|
|
|
|-
|[[STBT5:Leiomyosarcoma_of_bone|Leiomyosarcoma of bone]]
|Disease
|
|
|
|
Line 1,923: Line 2,069:
|
|
|
|
|-
|CHAPTER 3 (UNDIFFERENTIATED SMALL ROUND CELL SARCOMAS OF BONE AND SOFT TISSUE)
|
|
----
|
|
----
|
|
----
|-
|[[STBT5:Undifferentiated_pleomorphic_sarcoma|Undifferentiated pleomorphic sarcoma]]
|Disease
|
|
----
|
|
----
|
|
----
|
|
----
|
----
|
----
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|-
|-
|[[STBT5:Ewing_sarcoma|Ewing sarcoma]]
|[[STBT5:Bone_metastases|Bone metastases]]
|Disease
|Disease
|Sadeem Qdaisat
|10/1/23
|
|
|PENDING
|
|
|Working with Eric McGinnis
|
|
|2021 template added
|
|
|
|
Line 1,970: Line 2,095:
|
|
|-
|-
|[[STBT5:Round_cell_sarcoma_with_EWSR1-non-ETS_fusions|Round cell sarcoma with EWSR1-non-ETS fusions]]
|[[STBT5:Solitary_plasmacytoma_of_bone|Solitary plasmacytoma of bone]]
|Disease
|Disease
|
|
Line 1,979: Line 2,104:
|
|
|
|
|
|
|
|-
|
|[[STBT5:Primary_non-Hodgkin_lymphoma_of_bone|Primary non-Hodgkin lymphoma of bone]]
|
|Disease
|
|
|-
|[[STBT5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]]
|Disease
|
|
|
|
|
|
|
|
|
Line 2,002: Line 2,117:
|
|
|-
|-
|[[STBT5:Sarcoma_with_BCOR_genetic_alterations|Sarcoma with BCOR genetic alterations]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|-
|CHAPTER 4 (BONE TUMOURS)
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
|
!'''Date Assigned to Author'''
----
!'''Target Completion Date'''
|
!'''Author Content (Pending or Complete)'''
----
!'''Date Completed by Author'''!!'''Associate Editor'''
|
!'''Date of Last Editor Review'''
----
!'''Notes'''
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|[[STBT5:Subungual_exostosis|Subungual exostosis]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Bizarre_parosteal_osteochondromatous_proliferation|Bizarre parosteal osteochondromatous proliferation]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Periosteal_chondroma|Periosteal chondroma]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Enchondroma|Enchondroma]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Osteochondroma|Osteochondroma]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Chondroblastoma|Chondroblastoma]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Chondromyxoid_fibroma|Chondromyxoid fibroma]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Osteochondromyxoma|Osteochondromyxoma]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Synovial_chondromatosis|Synovial chondromatosis]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Central_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Central atypical cartilaginous tumour / chondrosarcoma, grade 1]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Secondary_peripheral_atypical_cartilaginous_tumour_/_chondrosarcoma,_grade_1|Secondary peripheral atypical cartilaginous tumour / chondrosarcoma, grade 1]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Central_chondrosarcoma,_grades_2_and_3|Central chondrosarcoma, grades 2 and 3]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Secondary_peripheral_chondrosarcoma,_grades_2_and_3|Secondary peripheral chondrosarcoma, grades 2 and 3]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Periosteal_chondrosarcoma|Periosteal chondrosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Clear_cell_chondrosarcoma|Clear cell chondrosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Dedifferentiated_chondrosarcoma_|Dedifferentiated chondrosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Osteoma|Osteoma]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Osteoid_osteoma_|Osteoid osteoma]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Osteoblastoma_|Osteoblastoma]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Low-grade_central_osteosarcoma|Low-grade central osteosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Osteosarcoma|Osteosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Parosteal_osteosarcoma_|Parosteal osteosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Periosteal_osteosarcoma_|Periosteal osteosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:High-grade_surface_osteosarcoma|High-grade surface osteosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Secondary_osteosarcoma|Secondary osteosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Desmoplastic_fibroma_of_bone|Desmoplastic fibroma of bone]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Fibrosarcoma_of_bone|Fibrosarcoma of bone]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Haemangioma_of_bone|Haemangioma of bone]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Epithelioid_haemangioma_of_bone|Epithelioid haemangioma of bone]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Epithelioid_haemangioendothelioma_of_bone|Epithelioid haemangioendothelioma of bone]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Angiosarcoma_of_bone|Angiosarcoma of bone]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Aneurysmal_bone_cyst|Aneurysmal bone cyst]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Giant_cell_tumour_of_bone_|Giant cell tumour of bone]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Non-ossifying_fibroma|Non-ossifying fibroma]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Benign_notochordal_cell_tumour_|Benign notochordal cell tumour]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Conventional_chordoma|Conventional chordoma]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Dedifferentiated_chordoma|Dedifferentiated chordoma]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Poorly_differentiated_chordoma|Poorly differentiated chordoma]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Chondromesenchymal_hamartoma_of_chest_wall|Chondromesenchymal hamartoma of chest wall]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Osteofibrous_dysplasia_|Osteofibrous dysplasia]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Adamantinoma_of_long_bones|Adamantinoma of long bones]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Simple_bone_cyst|Simple bone cyst]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Fibrocartilaginous_mesenchymoma|Fibrocartilaginous mesenchymoma]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Fibrous_dysplasia|Fibrous dysplasia]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Lipoma_and_hibernoma_of_bone|Lipoma and hibernoma of bone]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Leiomyosarcoma_of_bone|Leiomyosarcoma of bone]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Undifferentiated_pleomorphic_sarcoma|Undifferentiated pleomorphic sarcoma]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Bone_metastases|Bone metastases]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Solitary_plasmacytoma_of_bone|Solitary plasmacytoma of bone]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|[[STBT5:Primary_non-Hodgkin_lymphoma_of_bone|Primary non-Hodgkin lymphoma of bone]]
|Disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|-
|[[STBT5:Langerhans_cell_histiocytosis_|Langerhans cell histiocytosis]]
|[[STBT5:Langerhans_cell_histiocytosis_|Langerhans cell histiocytosis]]
|Disease
|Disease
|
|
|
|
|
|
|
|
|
Line 2,882: Line 2,139:
|[[STBT5:Erdheim-Chester_disease_|Erdheim-Chester disease]]
|[[STBT5:Erdheim-Chester_disease_|Erdheim-Chester disease]]
|Disease
|Disease
|
|
|
|
|
|
|
|
|
Line 2,898: Line 2,150:
|[[STBT5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
|[[STBT5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
|Disease
|Disease
|
|
|
|
|
|
|
|
|
Line 2,912: Line 2,159:
|
|
|-
|-
|CHAPTER 5 (GENETIC TUMOUR SYNDROMES OF SOFT TISSUE AND BONE)
|
|
----
====CHAPTER 5 (GENETIC TUMOUR SYNDROMES OF SOFT TISSUE AND BONE)====
|
----
|
----
|
----
|
----
|
|
----
----
Line 2,944: Line 2,182:
|[[STBT5:Enchondromatosis|Enchondromatosis]]
|[[STBT5:Enchondromatosis|Enchondromatosis]]
|Disease
|Disease
|
|
|
|
|
|
|
|
|
Line 2,960: Line 2,193:
|[[STBT5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]
|[[STBT5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]
|Disease
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|
|
|
|
|-
|-
|[[STBT5:McCune-Albright_syndrome|McCune-Albright syndrome]]
|[[STBT5:McCune-Albright_syndrome|McCune-Albright syndrome]]
|Disease
|Disease
|
|
|
|
|
|
|
|
|
Line 2,992: Line 2,215:
|[[STBT5:Multiple_osteochondromas|Multiple osteochondromas]]
|[[STBT5:Multiple_osteochondromas|Multiple osteochondromas]]
|Disease
|Disease
|
|
|
|
|
|
|
|
|
Line 3,008: Line 2,226:
|[[STBT5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
|[[STBT5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
|Disease
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|
|
|
|
|
|-
|-
|[[STBT5:Rothmund-Thomson_syndrome|Rothmund-Thomson syndrome]]
|[[STBT5:Rothmund-Thomson_syndrome|Rothmund-Thomson syndrome]]
|Disease
|Disease
|
|
|
|
|
|
|
|
|
Line 3,040: Line 2,248:
|[[STBT5:Werner_syndrome|Werner syndrome]]
|[[STBT5:Werner_syndrome|Werner syndrome]]
|Disease
|Disease
|
|
|
|
|
|
|
|
|
Retrieved from "https://test.ccga.io/index.php/STBT5:Volunteer_Assignments_and_Opportunities"